Medindia LOGIN REGISTER
Medindia
Advertisement

Disease Experts Warn of Untreatable Tuberculosis Risk

by Sheela Philomena on March 24, 2013 at 11:45 AM
 Disease Experts Warn of Untreatable Tuberculosis Risk

Disease experts called for more funding to fend off the risk of an untreatable strain of tuberculosis (TB) emerging.

In a series of papers in the Lancet medical journal to mark World TB Day on Sunday, they warned that health systems risked being overwhelmed by increasing numbers of drug-resistant TB patients.

Advertisement

Already, more than 30 percent of newly-diagnosed patients in parts of eastern Europe and central Asia have multi-drug resistant (MDR) TB, a form of the disease which does not respond to the two most potent drugs -- isoniazid and rifampin.

There were believed to be about 630,000 MDR cases out of some 12 million TB cases in 2011.

Extensively drug resistant (XDR) TB, thus far reported in 84 countries, does not respond to an even wider range of drugs.
Advertisement

"The widespread emergence of XDR tuberculosis could lead to virtually untreatable tuberculosis," wrote the authors of one study, led by Alimuddin Zumla, director of the Centre for Infectious Diseases and International Health at University College London Medical School.

"With ease of international travel and increased rates of MDR tuberculosis... the threat and range of the spread of untreatable tuberculosis is very real," they said.

TB was declared a global health emergency by the World Health Organisation (WHO) 20 years ago, but remains a leading cause of death by an infectious disease.

On its website, the UN agency says at least $1.6 billion (1.2 billion euros) is needed annually to prevent the spread of the disease.

For their part, the study authors urged "a radical change in political and scientific thinking".

"The global economic crisis and reduced investments in health services threaten national tuberculosis programmes and the gains made in global tuberculosis control," they wrote.

"The world needs to acknowledge the serious threat of drug-resistant tuberculosis before it overwhelms health systems."

Most needed are new drugs and better, quicker diagnostic tools.

In 2011, 8.7 million people fell ill with TB and 1.4 million died, said the WHO.

Over 95 percent of TB deaths occur in low- and middle-income countries, and it is among the top three causes of death for women aged 15 to 44.

In 2010, there were about 10 million orphans who had lost their parents to TB.

It is also a leading killer of people with HIV.

The death rate did drop by 41 percent between 1990 and 2011, according to the WHO, which says the world is on course to achieve the Millennium Development Goal of reversing the spread of TB by 2015.

"We have gained a lot of ground in TB, but it can easily be lost if we do not act now," WHO director general Margaret Chan said in a statement.

An airborne disease of the lungs, tuberculosis is usually treatable with a six-month course of antibiotics.

It is spread from person to person through the air and usually affects the lungs, but it can also affect other parts of the body such as the brain and kidneys.

Resistance to TB drugs develops when treatment fails to kill the bacteria that causes it -- either because the patient fails to follow their prescribed dosages or the drug doesn't work.

It can also be contracted through rare forms of the disease that are directly transmissible from person to person.

MDR TB in the United States can cost as much as $250,000 (200,000 euros) per patient to treat.

XDR TB requires about two years of treatment with even more expensive drugs that often cause side-effects and offer no guarantee of a cure.

Source: AFP
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Research News

Confronting the Painful Realities of Racial Bias in Health
Painful realities of racial discrimination and bias are increasingly acknowledged as harmful to the well-being.
Intricate Dance of Flaxseed, Gut Microbiome, and Breast Cancer Genes
Role of flaxseed in the relationship between gut microorganisms and mammary gland microRNAs has been uncovered by a new study.
MRNA Therapy's Promise for Chronic and Acute Liver Disease
New mRNA stem cell therapy, akin to COVID-19 vaccine tech, shows potential against chronic and acute liver diseases.
Could Light Therapy Be a Breakthrough for Alzheimer's?
Light therapy enhances sleep and psycho-behavioral symptoms in Alzheimer's patients with minimal side effects.
Does Twice Daily Stimulation Enhance Alzheimer's Mental Functions?
Electrical stimulation improves Alzheimer's patients' cognitive function and correlates with restored cortical plasticity.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Disease Experts Warn of Untreatable Tuberculosis Risk Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests